Defining the contribution of non-benzene sources of benzene metabolites in urine: implications for biomonitoring and risk assessment.
Arnold
Scott M
SM
The Dow Chemical Company, Toxicology & Environmental Research & Consulting, 1803 Building, Midland, MI 48674, United States. smarnold@dow.com
Price
Paul S
PS
Dryzga
Mark D
MD
D000111:Acetylcysteine / Q000031:analogs & derivatives / Q000652:urine; D001554:Benzene / Q000378:metabolism*; D001555:Benzene Derivatives / Q000652:urine*; D002396:Catechols / Q000652:urine; D004781:Environmental Exposure / Q000032:analysis*; D006801:Humans; D006873:Hydroquinones / Q000652:urine; D019800:Phenol / Q000652:urine; D018570:Risk Assessment; D013011:Sorbic Acid / Q000031:analogs & derivatives / Q000032:analysis
D001555:Benzene Derivatives; D002396:Catechols; D006873:Hydroquinones; D019800:Phenol; C005939:muconic acid; C053003:S-phenyl-N-acetylcysteine; D001554:Benzene; C034221:catechol; D000111:Acetylcysteine; D013011:Sorbic Acid; C031927:hydroquinone